Study in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Formulations of ABT-450

Completed · Phase 1

Conditions studied: Healthy

In brief

The objective of this study is to assess the relative bioavailability of two test tablet formulations of ABT-450 as compared to the ABT-450 hard gelatin capsule formulation as a reference.

Key facts

Study ID

NCT01091649

Run by

Abbott

People needed

40

Starts

2010-02-01

Expected to finish

2010-04-01

Last updated by the study team

2010-12-21

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Overall healthy subjects
• Non-childbearing potential females included

You may not qualify if…

• Positive test for HAV IgM, HBsAg, anti-HCV Ab or anti-HIV Ab
• Clinically significant cardiovascular, respiratory (except mild asthma), renal, gastrointestinal, hematologic, neurologic, thyroid, or any uncontrolled medical illness or psychiatric disorder
• Use of tobacco or nicotine-containing products with the 6-month period prior to study drug administration
• Abnormal screening laboratory results that are considered clinically significant by the investigator
• Pregnant or breastfeeding female; requirement for any OTC and/or prescription medication, vitamins and/or herbal supplements on a regular basis
• Previous exposure to ABT-450

Where it is running

• Site Reference ID/Investigator# 27781 — Waukegan, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.